The most recent short interest data has been released for the 06/15/2016 settlement date, which shows a 750,347 share decrease in total short interest for BioCryst Pharmaceuticals, Inc. (BCRX - Get Report), to 5,528,343, a decrease of 11.95% since 05/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for BCRX at the 06/15/2016 settlement increased to 967,828, as compared to 696,431 at the 05/31/2016 report. That brought "days to cover" down to 5.71, a 36.64% decrease from the 9.02 days to cover calculated at the previous short interest data release.The below chart shows the historical "days to cover" for BCRX at previous short interest release dates: A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where BCRX had been shorted as a hedge. The chart below shows the one year performance of BCRX shares, versus its 200 day moving average. Looking at this chart, BCRX's low point in its 52 week range is $1.63 per share, with $16.83 as the 52 week high point — that compares with a last trade of $2.66.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Amazon Returns 'Rainy Day in New York' Rights to Woody Allen: Report
Move raises doubts whether film will be released in U.S.
Qualcomm Aims to Resolve Royalty Battle With Huawei Amid U.S. Crackdown
The White House's moves against Huawei could complicate a resolution that Qualcomm is seeking with the Chinese telecom giant.